Geneva, March 20 -- International Clinical Trials Registry received information related to the study (CTRI/2026/02/104648) titled 'Treating Endometrial Cancer with Precision: A New Era of Personalized Medicine' on Feb. 24.
Study Type: Observational
Study Design:
Single Arm Study Method of generating randomization sequence:Not Applicable Method of allocation concealment:Not Applicable Blinding and masking:Not Applicable
Primary Sponsor: none
Condition:
Health Condition 1: C548- Malignant neoplasm of overlappingsites of corpus uteri
Intervention:
Intervention1: Nil: Nil
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 10-03-2026
Target Sample Size: 50
Countries of Recruitment:
India
To know more...